Firm seeks NIH grant to conduct study of epilepsy Dx tool

04/30/2013 | MedCityNews.com

A pair of doctors who founded Cognizance Biomarkers are working on a blood-based test to detect epilepsy more precisely and reduce overdiagnosis of the condition. The firm is applying for NIH funding to conduct a proof of principle study for the assay, which is intended to locate an anti-inflammatory protein originating from the brain that is often found in low concentrations in epilepsy patients.

View Full Article in:

MedCityNews.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Claims Director
PacificSource
Springfield, OR
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA